On March 23, 2022, Brooklyn ImmunoTherapeutics, Inc. closed the transaction. The transaction included participation from single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.855 USD | +8.48% | +3.64% | +3.34% |
03-15 | North American Morning Briefing : Inflation -2- | DJ |
03-14 | Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+3.34% | 10.04M | |
+25.69% | 47.9B | |
+47.30% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ERNA Stock
- News Eterna Therapeutics Inc.
- Brooklyn ImmunoTherapeutics, Inc. announced that it has received $11.999999 million in funding